Somatostatin Receptor SSTR-2a Expression Is a Stronger Predictor for Survival Than Ki-67 in Pancreatic Neuroendocrine Tumors.

Mehta, Shreya; de Reuver, Philip R; Gill, Preetjote; Andrici, Juliana; D'Urso, Lisa; Mittal, Anubhav; Pavlakis, Nick; Clarke, Stephen; Samra, Jaswinder S; Gill, Anthony J

Mehta, Shreya; de Reuver, Philip R; Gill, Preetjote; Andrici, Juliana; D'Urso, Lisa; Mittal, Anubhav; Pavlakis, Nick; Clarke, Stephen; Samra, Jaswinder S; Gill, Anthony J.

Affiliation

Mehta S; From Department of Gastrointestinal Surgery, Royal North Shore Hospital and North Shore Private Hospital, University of Sydney, New South Wales, Australia (SM, PDR, PG, AM, JSS); Department of Medical Oncology, Royal North Shore Hospital and North Shore Private Hospital, University of Sydney, New South Wales, Australia (NP, SC); Macquarie University Hospital, Macquarie University, New South Wales, Australia (JSS); and Department of Anatomical Pathology Royal North Shore Hospital, Cancer Diagnosi

Medicine (Baltimore) ; 94(40): e1281, 2015 Oct.

Article in En | MEDLINE | ID: mdl-26447992

Subject(s)

Neuroendocrine Tumors/mortality; Pancreatic Neoplasms/mortality; Receptors, Somatostatin/analysis; Adolescent; Adult; Aged; Aged, 80 and over; Cohort Studies; Humans; Immunochemistry; Ki-67 Antigen/analysis; Middle Aged; Neuroendocrine Tumors/chemistry; Pancreatic Neoplasms/chemistry; Prognosis; Retrospective Studies

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Pancreatic Neoplasms / Receptors, Somatostatin / Neuroendocrine Tumors Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Humans / Middle aged Language: En Year: 2015 Type: Article

Fulltext

XML

PubMed Links

Search on Google